Close

Analyst Ratings for PDL BioPharma (PDLI)

PDLI Rating Summary

  |   Expand Research on PDLI
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 5 / 10
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
10/11/2011 RBC Capital N/A Downgrade Sector Perform
(N/A)
6.00
(N/A)
5.70
(6.14)
7.72% Details
1/5/2011 Global Hunter Securities N/A Downgrade Accumulate
(N/A)
N/A
(N/A)
6.25
(6.14)
-1.76% Details